- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Duopharma Biotech Bhd (DUOP)
Duopharma Biotech Bhd stock price live, this page displays KL DUOP stock exchange data. View the DUOP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Duopharma Biotech Bhd real time stock price chart below.
What Is the Duopharma Biotech Bhd Stock Price Today?
The Duopharma Biotech Bhd stock price today is 1.340.
What Is the Stock Symbol for Duopharma Biotech Bhd?
The stock symbol for Duopharma Biotech Bhd is ""DUOP.""
What Stock Exchange Does Duopharma Biotech Bhd Trade On?
Duopharma Biotech Bhd is listed and trades on the Kuala Lumpur stock exchange.
Is Duopharma Biotech Bhd a Good Stock to Buy?
Determining whether Duopharma Biotech Bhd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DUOP quote. (ISIN: MYL7148OO009)
What Is the Duopharma Biotech Bhd Stock Price Today?
The Duopharma Biotech Bhd stock price today is 1.340.
What Is the Stock Symbol for Duopharma Biotech Bhd?
The stock symbol for Duopharma Biotech Bhd is ""DUOP.""
What Stock Exchange Does Duopharma Biotech Bhd Trade On?
Duopharma Biotech Bhd is listed and trades on the Kuala Lumpur stock exchange.
Is Duopharma Biotech Bhd a Good Stock to Buy?
Determining whether Duopharma Biotech Bhd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DUOP quote. (ISIN: MYL7148OO009)
Kuala Lumpur
Currency in MYR
1.340
-0.030(-2.19%)
Closed·
Fair Value
An estimate of a Duopharma Biotech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.340
1.360
52 wk Range
1.070
1.460
DUOP Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
DUOP is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Duopharma Biotech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.3401.360
52 wk Range
1.0701.460
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.24%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.24%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
DUOP Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Duopharma Biotech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
1.678
Upside
+25.22%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Duopharma Biotech Bhd Company Profile
Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products, such as vitamins, minerals, and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system, musculo-skeletal system, anti-infectives, and others. It also provides specialty pharmaceutical drugs for targeted conditions, biosimilar products, and medical devices and consumables to patients with conditions, including diabetes, cancer, cardiovascular, renal, and other diseases. The company’s product portfolio includes covasc, crystorvas, and vytocor; lebreta, and krabeva; and unihepa, erysaa, bi-haemosol, and haemosol. In addition, it offers its products under the Champs, Flavettes, Eye Glo, Proviton, Naturalle, IRORO Nutreatment, and Uphamol brands. The company was formerly known as CCM Duopharma Biotech Berhad and changed its name to Duopharma Biotech Berhad in February 2019. The company was founded in 1978 and is based in Klang, Malaysia.
Compare DUOP to Peers and Sector
Metrics to compare | DUOP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDUOPPeersSector | |
|---|---|---|---|---|
P/E Ratio | 17.7x | 22.4x | −0.5x | |
PEG Ratio | 0.30 | −0.71 | 0.00 | |
Price/Book | 1.8x | 1.9x | 2.6x | |
Price / LTM Sales | 1.5x | 2.1x | 3.2x | |
Upside (Analyst Target) | 24.1% | 13.9% | 41.2% | |
Fair Value Upside | Unlock | 13.6% | 6.2% | Unlock |
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 1.678
(+25.22% Upside)
Earnings
Latest Release
May 15, 2025
EPS / Forecast
0.027 / --
Revenue / Forecast
262.70M / --
People Also Watch
FAQ
What Stock Exchange Does Duopharma Biotech Trade On?
Duopharma Biotech is listed and trades on the Kuala Lumpur Stock Exchange stock exchange.
What Is the Stock Symbol for Duopharma Biotech?
The stock symbol for Duopharma Biotech is "DUOP."
What Is the Duopharma Biotech Market Cap?
As of today, Duopharma Biotech market cap is 1.30B.
What Is Duopharma Biotech's Earnings Per Share (TTM)?
The Duopharma Biotech EPS (TTM) is 0.08.
When Is the Next Duopharma Biotech Earnings Date?
Duopharma Biotech will release its next earnings report on 13 Aug 2025.
From a Technical Analysis Perspective, Is DUOP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Duopharma Biotech Stock Split?
Duopharma Biotech has split 5 times.
How Many Employees Does Duopharma Biotech Have?
Duopharma Biotech has 1957 employees.
What is the current trading status of Duopharma Biotech (DUOP)?
As of 29 Jul 2025, Duopharma Biotech (DUOP) is trading at a price of 1.34, with a previous close of 1.37. The stock has fluctuated within a day range of 1.34 to 1.36, while its 52-week range spans from 1.07 to 1.46.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.